1. Home
  2. UPC vs PRFX Comparison

UPC vs PRFX Comparison

Compare UPC & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPC
  • PRFX
  • Stock Information
  • Founded
  • UPC 1998
  • PRFX 2007
  • Country
  • UPC China
  • PRFX Israel
  • Employees
  • UPC N/A
  • PRFX N/A
  • Industry
  • UPC Biotechnology: Pharmaceutical Preparations
  • PRFX Biotechnology: Pharmaceutical Preparations
  • Sector
  • UPC Health Care
  • PRFX Health Care
  • Exchange
  • UPC Nasdaq
  • PRFX Nasdaq
  • Market Cap
  • UPC 2.1M
  • PRFX 2.2M
  • IPO Year
  • UPC 2021
  • PRFX 2020
  • Fundamental
  • Price
  • UPC $3.53
  • PRFX $0.86
  • Analyst Decision
  • UPC
  • PRFX
  • Analyst Count
  • UPC 0
  • PRFX 0
  • Target Price
  • UPC N/A
  • PRFX N/A
  • AVG Volume (30 Days)
  • UPC 17.9K
  • PRFX 694.5K
  • Earning Date
  • UPC 01-01-0001
  • PRFX 11-14-2025
  • Dividend Yield
  • UPC N/A
  • PRFX N/A
  • EPS Growth
  • UPC N/A
  • PRFX N/A
  • EPS
  • UPC N/A
  • PRFX N/A
  • Revenue
  • UPC $19,293,003.00
  • PRFX N/A
  • Revenue This Year
  • UPC N/A
  • PRFX N/A
  • Revenue Next Year
  • UPC N/A
  • PRFX N/A
  • P/E Ratio
  • UPC N/A
  • PRFX N/A
  • Revenue Growth
  • UPC N/A
  • PRFX N/A
  • 52 Week Low
  • UPC $2.51
  • PRFX $0.80
  • 52 Week High
  • UPC $197.20
  • PRFX $16.63
  • Technical
  • Relative Strength Index (RSI)
  • UPC 37.99
  • PRFX 35.08
  • Support Level
  • UPC $3.35
  • PRFX $0.88
  • Resistance Level
  • UPC $3.81
  • PRFX $0.98
  • Average True Range (ATR)
  • UPC 0.28
  • PRFX 0.09
  • MACD
  • UPC -0.06
  • PRFX -0.01
  • Stochastic Oscillator
  • UPC 14.91
  • PRFX 18.67

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About PRFX PainReform Ltd.

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Share on Social Networks: